Antibody Drug Tested as New Tool against Malaria

2022-11-07

00:00 / 00:00
复读宝 RABC v8.0beta 复读机按钮使用说明
播放/暂停
停止
播放时:倒退3秒/复读时:回退AB段
播放时:快进3秒/复读时:前进AB段
拖动:改变速度/点击:恢复正常速度1.0
拖动改变复读暂停时间
点击:复读最近5秒/拖动:改变复读次数
设置A点
设置B点
取消复读并清除AB点
播放一行
停止播放
后退一行
前进一行
复读一行
复读多行
变速复读一行
变速复读多行
LRC
TXT
大字
小字
滚动
全页
1
  • A new study carried out in the West African nation of Mali found that an experimental drug protected adults against malaria for at least six months.
  • 2
  • The one-dose drug is the latest possible treatment for the disease spread by mosquitos.
  • 3
  • Malaria killed more than 620,000 people in 2020 and sickened 241 million.
  • 4
  • They were mainly children under the age of 5 in Africa.
  • 5
  • The World Health Organization is releasing the first malaria vaccine for children.
  • 6
  • But it is just 30 percent effective and requires four doses.
  • 7
  • The new study tested a very different idea.
  • 8
  • The drug gives people a large dose of lab-made malaria-fighting antibodies.
  • 9
  • The vaccine depends on the immune system to make enough of those same infection-blockers after vaccination.
  • 10
  • Dr. Kassoum Kayentao is with the University of Sciences, Techniques and Technologies in Bamako, Mali.
  • 11
  • He helped lead the study in two small villages in Mali.
  • 12
  • He said the "available vaccine doesn't protect enough people."
  • 13
  • During malaria season in some places in Mali, people are bitten by infected mosquitoes on an average of twice a day.
  • 14
  • The experimental antibody was created by researchers at the U.S. National Institutes of Health.
  • 15
  • It is given intravenously, or directly into the veins.
  • 16
  • The drug would be difficult to release to a large amount of people.
  • 17
  • But scientists are also testing a shot version of the treatment, which would be easier to give out.
  • 18
  • The U.S. government research was published Monday in the New England Journal of Medicine and was presented at a medical meeting in Seattle.
  • 19
  • The antibody works by breaking the life cycle of the parasite, which is spread through mosquito bites.
  • 20
  • It targets parasites early before they enter the liver, where they can grow and multiply.
  • 21
  • The drug was created from an antibody taken from a volunteer who received a malaria vaccine.
  • 22
  • The research involved 330 adults in Mali.
  • 23
  • The study participants got either one of two different antibody doses or a placebo - a substance given to a patient like a drug but has no physical effect on the patient.
  • 24
  • All participants were tested for malaria infection every two weeks for 24 weeks.
  • 25
  • Anyone who got sick was treated.
  • 26
  • Infections were found by blood test in 20 people who got the higher dose.
  • 27
  • Infections were found in 39 people who got the lower dose.
  • 28
  • Eighty-six people who got the placebo became infected during the study period.
  • 29
  • The higher dose was 88 percent effective, compared to the placebo.
  • 30
  • The lower dose was 75 percent effective.
  • 31
  • Protection might last during the several months of malaria season.
  • 32
  • The cost is not yet known. But one estimate suggests lab-made antibodies could be given for just $5 per child per malaria season.
  • 33
  • Dr. Johanna Daily is with the Albert Einstein College of Medicine in New York.
  • 34
  • She was not involved in the study.
  • 35
  • She said lab-made antibodies are used to treat cancer, autoimmune diseases and COVID-19.
  • 36
  • "The good news is now we have another, immune-based therapy to try to control malaria," she said.
  • 37
  • I'm Dan Novak.
  • 1
  • A new study carried out in the West African nation of Mali found that an experimental drug protected adults against malaria for at least six months. The one-dose drug is the latest possible treatment for the disease spread by mosquitos.
  • 2
  • Malaria killed more than 620,000 people in 2020 and sickened 241 million. They were mainly children under the age of 5 in Africa.
  • 3
  • The World Health Organization is releasing the first malaria vaccine for children. But it is just 30 percent effective and requires four doses.
  • 4
  • The new study tested a very different idea. The drug gives people a large dose of lab-made malaria-fighting antibodies. The vaccine depends on the immune system to make enough of those same infection-blockers after vaccination.
  • 5
  • Dr. Kassoum Kayentao is with the University of Sciences, Techniques and Technologies in Bamako, Mali. He helped lead the study in two small villages in Mali. He said the "available vaccine doesn't protect enough people."
  • 6
  • During malaria season in some places in Mali, people are bitten by infected mosquitoes on an average of twice a day.
  • 7
  • The experimental antibody was created by researchers at the U.S. National Institutes of Health. It is given intravenously, or directly into the veins.
  • 8
  • The drug would be difficult to release to a large amount of people. But scientists are also testing a shot version of the treatment, which would be easier to give out.
  • 9
  • The U.S. government research was published Monday in the New England Journal of Medicine and was presented at a medical meeting in Seattle.
  • 10
  • The antibody works by breaking the life cycle of the parasite, which is spread through mosquito bites. It targets parasites early before they enter the liver, where they can grow and multiply. The drug was created from an antibody taken from a volunteer who received a malaria vaccine.
  • 11
  • The research involved 330 adults in Mali. The study participants got either one of two different antibody doses or a placebo - a substance given to a patient like a drug but has no physical effect on the patient. All participants were tested for malaria infection every two weeks for 24 weeks. Anyone who got sick was treated.
  • 12
  • Infections were found by blood test in 20 people who got the higher dose. Infections were found in 39 people who got the lower dose. Eighty-six people who got the placebo became infected during the study period.
  • 13
  • The higher dose was 88 percent effective, compared to the placebo. The lower dose was 75 percent effective.
  • 14
  • Protection might last during the several months of malaria season.
  • 15
  • The cost is not yet known. But one estimate suggests lab-made antibodies could be given for just $5 per child per malaria season.
  • 16
  • Dr. Johanna Daily is with the Albert Einstein College of Medicine in New York. She was not involved in the study. She said lab-made antibodies are used to treat cancer, autoimmune diseases and COVID-19.
  • 17
  • "The good news is now we have another, immune-based therapy to try to control malaria," she said.
  • 18
  • I'm Dan Novak.
  • 19
  • Dan Novak adapted this story for VOA Learning English based on reporting by The Associated Press.
  • 20
  • ______________________________________________________________________
  • 21
  • Words in This Story
  • 22
  • dose - n. the amount of a medicine, drug, or vitamin that is taken at one time
  • 23
  • antibody - n. a substance produced by the body to fight disease
  • 24
  • immune system - n. the system that protects your body from diseases and infections
  • 25
  • vein - n. any one of the tubes that carry blood from parts of the body back to the heart
  • 26
  • cycle - n. a set of events or actions that happen again and again in the same order
  • 27
  • parasite - n. an animal or plant that lives in or on another animal or plant and gets food or protection from it
  • 28
  • multiply - v. to increase greatly in number or amount
  • 29
  • participant - n. a person who is involved in an activity or event
  • 30
  • therapy - n. the treatment of physical or mental illnesses